Galactose increases residual α-galactosidase A activity in patients with Fabry disease

被引：0
|
作者：
Antuzzi, D. [1 ]
Zampetti, A. [2 ]
Castorina, M. [1 ]
Feliciani, C. [2 ]
Ricci, R. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Pediat, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Inst Dermatol, Rome, Italy
来源：
ACTA PAEDIATRICA | 2008年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] Fabry disease: Enzymatic properties of fifteen -galactosidase A mutations found in Fabry patients with residual enzyme activity.
    Chang, HH
    Wu, HL
    Ishii, S
    Fan, JQ
    GLYCOBIOLOGY, 2000, 10 (10) : 1136 - 1136
  • [2] FABRY DISEASE - CLASSIC HEMIZYGOTE AND RESIDUAL ALPHA-GALACTOSIDASE A ACTIVITY
    PRAVATA, G
    NOTO, G
    ARICO, M
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (05) : 367 - 369
  • [3] α-galactosidase activity increases after short-term treatment with migalastat in patients with Fabry disease
    Nowak, Albina
    Desnick, Robert J.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S107 - S108
  • [4] FABRY DISEASE - AN ASYMPTOMATIC HEMIZYGOTE WITH SIGNIFICANT RESIDUAL ALPHA-GALACTOSIDASE A ACTIVITY
    BISHOP, DF
    GRABOWSKI, GA
    DESNICK, RJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1981, 33 (06) : A71 - A71
  • [5] GALACTOSE STABILIZES VARIOUS MISSENSE MUTANTS OF ALPHA-GALACTOSIDASE IN FABRY DISEASE
    OKUMIYA, T
    ISHII, S
    TAKENAKA, T
    KASE, R
    KAMEI, S
    SAKURABA, H
    SUZUKI, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (03) : 1219 - 1224
  • [6] PROPERTIES OF RESIDUAL ALPHA-GALACTOSIDASE ACTIVITY IN TISSUES OF A FABRY HEMIZYGOTE
    RIETRA, PJGM
    VANDENBERGH, FAJTM
    TAGER, JM
    CLINICA CHIMICA ACTA, 1975, 62 (03) : 401 - 413
  • [7] A theoretical study on binding and stabilization of galactose and novel galactose analogues to the human ?-galactosidase A variant causing Fabry disease
    Klaewkla, Methus
    Prousoontorn, Jittithorn
    Charoenwongpaiboon, Thanapon
    BIOPHYSICAL CHEMISTRY, 2023, 292
  • [8] Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: Pitfalls of mutation analyses in patients with low α-galactosidase A activity
    Yoshimitsu, Makoto
    Higuchi, Koji
    Miyata, Masaaki
    Devine, Sean
    Mattman, Andre
    Sirrs, Sandra
    Medin, Jeffrey A.
    Tei, Chuwa
    Takenaka, Toshihiro
    JOURNAL OF CARDIOLOGY, 2011, 57 (03) : 345 - 353
  • [9] Identification of Fabry's disease by the screening of α-galactosidase A activity in male and female hemodialysis patients
    Tanaka, M
    Ohashi, T
    Kobayashi, M
    Eto, Y
    Miyamura, N
    Nishida, K
    Araki, E
    Itoh, K
    Matsushita, K
    Hara, M
    Kuwahara, K
    Nakano, T
    Yasumoto, N
    Nonoguchi, H
    Tomita, K
    CLINICAL NEPHROLOGY, 2005, 64 (04) : 281 - 287
  • [10] HYPERTROPHIC CARDIOMYOPATHY IN LATE-ONSET VARIANT OF FABRY DISEASE WITH HIGH RESIDUAL ACTIVITY OF ALPHA-GALACTOSIDASE-A
    NAGAO, Y
    NAKASHIMA, H
    FUKUHARA, Y
    SHIMMOTO, M
    OSHIMA, A
    IKARI, Y
    MORI, Y
    SAKURABA, H
    SUZUKI, Y
    CLINICAL GENETICS, 1991, 39 (03) : 233 - 237
12345